Journal
FRONTIERS IN MICROBIOLOGY
Volume 11, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2020.598024
Keywords
maipomycin A; biofilm inhibition; Gram-negative bacteria; iron chelator; antibiotics enhancer
Categories
Funding
- Scientific and Technical Innovation Council of Shenzhen [KQJSCX20170727101743831]
- National Natural Science Foundation of China [41830535]
- China National Key Research and Development Project [2018YFA0902500]
- Science and Technology Project from Shenzhen Bureau of Science, Technology [JCYJ20180305123659726]
Ask authors/readers for more resources
Pathogenic bacterial biofilms are difficult to eradicate and can develop antibiotic resistance. MaiA, a compound isolated from a rare actinomycete strain, shows broad-spectrum anti-biofilm activities against Gram-negative bacteria and can enhance the efficacy of certain antibiotics, potentially serving as an effective agent to prevent biofilm formation.
Pathogenic bacterial biofilms play an important role in recurrent nosocomial and medical device-related infections. Once occurred, the complex structure of the biofilm promotes the development of antibiotic resistance and becomes extremely difficult to eradicate. Here we describe a novel and effective anti-biofilm compound maipomycin A (MaiA), which was isolated from the metabolites of a rare actinomycete strain Kibdelosporangium phytohabitans XY-R10. Its structure was deduced from analyses of spectral data and confirmed by single-crystal X-ray crystallography. This natural product demonstrated a broad spectrum of anti-biofilm activities against Gram-negative bacteria. Interestingly, the addition of Fe(II) or Fe(III) ions could block the biofilm inhibition activity of MaiA because it is an iron chelator. However, not all iron chelators showed biofilm inhibition activity, suggesting that MaiA prevents biofilm formation through a specific yet currently undefined pathway. Furthermore, MaiA acts as a synergist to enhance colistin efficacy against Acinetobacter baumannii. Our results indicate that MaiA may potentially serve as an effective antibiofilm agent to prevent Gram-negative biofilm formation in future clinical applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available